DURHAM, NC– Chesson Labs, a Durham-based healthcare products company, announced today it has completed a $3.3 million Series A financing. The Company plans to primarily
use the investment to fund future product development efforts and for the introduction of its products to the healthcare marketplace.
“This funding will allow us to continue to develop exciting products in several key strategic healthcare markets,” declared Scott Neuville, Chesson Labs President and CEO. “We appreciate the confidence shown by our investors and individuals in the medical community,” he continued.
Scott Neuville joined Chesson Labs in January. Neuville brings significant operational and leadership experience in several healthcare arenas to Chesson Labs.
“Chesson Labs is fortunate to have Scott Neuville as President and CEO,” said Founder Jerry Chesson. “Scott brings with him the experience and leadership needed by the Company to bring our products to market.”

http://www.chessonlabs.com/documents/ChessonLabsSeriesAFINALPR03032008.pdf